Male Infertility Market Is Expected To Reach $ 5.03 Billion By 2027


 San Francisco, 18 Dec 2020: The Report Male Infertility Market Size, Share & Trends Analysis Report By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination), By Treatment, By Region, And Segment Forecasts, 2020 - 2027

The global male infertility market size is expected to reach USD 5.03 billion by 2027, expanding at a CAGR of 4.7% over the forecast period, according to a new report by Grand View Research, Inc. Advancements in diagnostic tests and increasing infertility in males are some of the major factors driving the market for male infertility. In addition, lifestyle-associated diseases causing infertility, rising obesity, and growing aging population are likely to boost the market growth during the forecast period. In U.S., one-third of infertility cases are due to female factors, one third due to male factors, and the remaining one third is unknown.

DNA fragmentation technique emerged the largest test segment in the market in 2019 and is expected to maintain its lead during the forecast period. Increasing adoption in developed countries and high cost due to higher sensitivity and reliable analysis of sperm DNA integrity are the key factors driving the segment.

On the basis of treatment, the Assisted Reproductive Technology (ART) and Varicocele Surgery segment dominated the market for male infertility in 2019 due to its high success rate. Intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) are the most commonly used ARTs. Medications include hormonal therapy and corticosteroids, however they are effective in very few cases.

Partnerships and agreements among key manufacturers are expected to boost the market growth in the coming years. For instance, in July 2019, Vitrolife entered into a collaboration with Prime Tech for the development and exclusive marketing of the Piezo technique, for improved Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except Malaysia, Thailand, and Japan. Additionally, Vitrolife will initiate the regulatory approval procedures in various markets for the future commercialization of the technology.

Access Research Report of Male Infertility Market https://www.grandviewresearch.com/industry-analysis/male-infertility-market

Male Infertility Market Report Highlights

  • Based on test, DNA fragmentation technique dominated the market in 2019 and is estimated to witness significant growth over the forecast period
  • Oxidative stress analysis test is gaining popularity due to the accurate determination of reactive oxygen species. In March 2018, Aytu BioScience, Inc. received registration from COFEPRIS in Mexico for MiOXSYS System, which is used for diagnosing male infertility
  • Europe dominated the male infertility market in 2019 and is expected to maintain its lead during the forecast period due to high adoption of costlier treatment, strong diagnosis rate, and increased awareness
  • Asia Pacific is projected to witness substantial growth over the forecast period owing to increasing investment by several clinics and pharmaceutical companies and growing healthcare expenditure
  • Some key players of the market are Bayer Healthcare, Inc.; EMD Sereno; Aytu BioScience, Inc.; Halotech DNA SL; Intas Pharmaceuticals Ltd.; Cadila Healthcare Ltd.; Andrology Solutions; and SCSA diagnostics, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global male infertility market based on test, treatment, and region:

Male Infertility Test Outlook (Revenue, USD Million, 2015 - 2027)

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

Male Infertility Treatment Outlook (Revenue, USD Million, 2015 - 2027)

  • Assisted Reproductive Technology and Varicocele Surgery
  • Medication

Male Infertility Regional Outlook (Revenue, USD Million, 2015 - 2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Male Infertility Market @ https://www.grandviewresearch.com/press-release/global-male-infertility-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Comments

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Biomaterials Market Size Poised To Reach USD 348.4 Billion By 2027

Latin America Nutrition & Dietary Supplements Market Expected To Grow At A CAGR 8.8% For The Forecast Period From 2017 To 2025 : Grand View Research Inc.